3B BlackBio Dx has scheduled its 54th Annual General Meeting for September 29, 2026. The meeting will convene to adopt the audited financial statements for FY26 and declare a final dividend of ₹5 per equity share.

The company, formerly known as Kilpest India Limited, will hold the meeting via Video Conferencing or Other Audio Visual Means at 11:30 am IST. Shareholders on record as of September 22, 2026, will be eligible for the dividend payout and voting rights.

Key Agenda Items

The ordinary business includes the adoption of standalone and consolidated financial statements for the year ended March 31, 2026. The Board recommends the final dividend out of current profits, subject to member approval.

Special business items focus on governance and audit compliance:

• Reappointment of Mrs. Mithla Dubey as a Non-Executive Director liable to retire by rotation.
• Ratification of remuneration for Cost Auditors Sanjay Kasliwal & Associates.

Director Reappointment

Mrs. Mithla Dubey (DIN: 03597415), aged 79, seeks reappointment as a Non-Executive Director. Under SEBI Listing Regulations, a special resolution is required for directors aged 75 or above. She serves as a promoter and woman director, holding 10,59,770 equity shares as of March 31, 2026.

Audit Remuneration

The Board seeks ratification for a remuneration of ₹50,000 payable to Sanjay Kasliwal & Associates for conducting the cost audit for the financial year ending March 31, 2027. This appointment follows a recommendation by the Audit Committee.

E-Voting and Book Closure

Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has provided a remote e-voting facility. The cut-off date for determining eligibility is Tuesday, September 22, 2026.

The remote e-voting period commences on Saturday, September 26, 2026, at 9.00 am and ends on Monday, September 28, 2026, at 5.00 pm IST.

The Register of Members and Share Transfer Books will remain closed from Wednesday, September 23, 2026, to Tuesday, September 29, 2026 (both days inclusive) for the purpose of the AGM and dividend payment.

Annual Report Access

In compliance with Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has sent letters to shareholders who have not registered their email addresses. These shareholders can access the Annual Report for the Financial Year 2025-26 via the company’s website at www.kilpest.com under Investor Info > 3B BlackBio Dx Limited Annual Report 2026. The report is also available on the BSE website.

3B BlackBio Dx Ltd concluded its one-on-one virtual investor meeting with Param Capital on Saturday, August 29, 2026. The session ran from 1:00 pm to 2:00 pm India Time.

The interaction focused on the company’s financial performance for the first quarter of FY27. Management used the Q1-FY27 Investor Presentation, previously intimated to stock exchanges via Ref. No. P-66/2026-27/27 dated August 13, 2026, as the basis for discussion.

Meeting Outcome

The company confirmed that only information available in the public domain was discussed during the call. No unpublished price-sensitive information was shared with the investor. This disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Nikhil Kuber Dubey, Whole Time Director, signed the disclosure filed with the Bombay Stock Exchange.